AbbVie Inc.’s Allergan Aesthetics announced the acquisition of Soliton Inc. in a definitive agreement that is valued at $550 million. Allergan Aesthetics will pay $22.60 per share for each outstanding Soliton share.
Dentsu International announced on April 20 the launch of dentsu health, a global solution. Drawing upon the expertise of dentsu’s global network of 2,000 health marketing experts across 85 markets in EMEA, APAC and the Americas, dentsu health is poised to become one of the top global healthcare agencies.
Thermo Fisher Scientific Inc. is acquiring contract researcher PPD Inc. for $17.4 billion as the medical device maker adds more muscle to the company’s pharmaceutical services business.
Mayo Clinic launched two new tech venture companies designed to harness artificial intelligence (AI) and medical algorithms and create “software as medical devices” that clinicians can use to improve treatment across different diseases.
Studies have concluded that chatbots have the potential in treating mental health issues and could be used as an effective tool for delivering cognitive behavioral therapy.
Boston Scientific will pay $189 million to settle a multi-state lawsuit over the marketing of the company’s surgical mesh devices.
Thermo Fisher Scientific is acquiring Mesa Biotech for about $450 million in cash, and will pay an additional $100 million in cash after certain milestones are hit.
BioSpace reviews whose wallets got thicker in the biopharma industry, from largest to smallest, during the Nov. 11-17 period
Shares of Inovio Pharmaceuticals plunged in trading after the company reported the U.S. Food and Drug Administration placed a partial clinical hold on the planned Phase II/III study of the Covid-19 vaccine candidate INO-4800.
Soliton Inc. selected Greater Than One Group as the medical device company’s integrated marketing agency.
